Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today

E-ISSN： 1873-4286|15|14|1563-1586

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.14, 2009-05, pp. : 1563-1586

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New approaches to developing antidepressants by enhancing monoaminergic neurotransmission

By Bymaster Frank P McNamara Robert K Tran Pierre V

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 531-543

Informa Healthcare

Access to resources Recommend Favorite

Non-Monoaminergic Targets for the Development of Antidepressants: Focus on Neuropeptides

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 1, 2013-01 ,pp. : 2-10

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus

By Dremencov E. Gur E. Lerer B. Newman M.E.

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 5, 2003-08 ,pp. : 729-739

Elsevier

Access to resources Recommend Favorite

Drug Discovery Today

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 1, 2003-01 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Drug Discovery to Assess Cholinergic Neurotransmission: A Systematic Review

Current Drug Discovery Technologies, Vol. 5, Iss. 3, 2008-09 ,pp. : 236-249

Bentham Science Publishers

Access to resources Recommend Favorite